All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Genomewide association studies (GWAS) have so far underperformed in identifying genetic contribution to disease, but they have demonstrated that most genetic contributors to complex diseases consist of small contributions of relatively common variants, rather than large contributions of rare ones. Scientists at the Finnish University of Helsinki have developed a method to calculate a polygenic risk score for such common variants and used it to identify genetic contributions to migraine risk.